CapsoVision (CV) Common Equity (2024 - 2025)
CapsoVision recorded quarterly Common Equity of $13.3 million in Q4 2025, down 35.13% quarter-over-quarter from $20.4 million in Q3 2025, and up 110.24% year-over-year from $6.3 million in Q4 2024.
CapsoVision's Common Equity history runs 2 years deep, the most recent figure standing at $13.3 million for Q4 2025.
- In Q4 2025, Common Equity rose 110.24% year-over-year to $13.3 million; the TTM figure through Dec 2025 stood at $13.3 million (up 110.24% YoY), while the FY2025 annual figure was $13.3 million, up 110.24% from the prior year.
- Common Equity came in at $13.3 million for Q4 2025 at CapsoVision, down from $20.4 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $20.4 million in Q3 2025 to a low of -$139.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 48.99 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.68 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.20 Bn |
| 10 | CapsoVision | 167.59 Mn | 157.48 Mn | 1.95 Mn | 13.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.26 Mn |
| Sep 30, 2025 | 20.44 Mn |
| Jun 30, 2025 | -138.99 Mn |
| Dec 31, 2024 | -129.51 Mn |
| Sep 30, 2024 | -124.99 Mn |
| Jun 30, 2024 | -119.21 Mn |